Genomics
High-resolution insights for every stage of development
Comprehensive genomics and NGS services with WGS, WES, RNASeq, and bioinformatics to deliver high-quality, actionable clinical research data.
Comprehensive genomic testing
Broad capabilities for complex questions
We offer a full suite of genomic technologies to characterize mechanisms, quantify biological change, and support clinical decision‑making.
-
Targeted, whole‑gene, and whole‑genome approaches
-
Copy number, vector integration, and variant analysis
Advanced NGS expertise
Precision and sensitivity in every read
Our team develops, validates, and executes NGS assays designed for diverse sample types, low‑input material, and challenging study requirements.
-
Amplicon and hybrid‑capture methods
-
AAV and lentiviral vector analysis
-
Viral shedding and biodistribution
-
Microbial and metagenomic profiling
Support for cell & gene therapies
Genomics built for advanced modalities
We provide the specialized assays essential for engineered therapies.
-
Transgene and vector copy number
-
Integration site analysis
-
Persistence and durability assessments
-
Genomic safety and off‑target evaluations
Regulatory‑ready quality
High standards for clinical and post‑marketing needs
From method development to GxP‑validated workflows, we generate reliable genomic data aligned with regulatory expectations across global agencies.
Flexible sample handling
Designed for complex matrices and limited volume
Our workflows accommodate a wide range of sample types, including FFPE, whole blood, plasma, CSF, tissue, and microsamples.
Webinar
NGS Strategies for Vaccine Development and Surveillance of Respiratory Viruses
Explore how next-generation sequencing (NGS) is advancing the detection and characterization of respiratory RNA viruses in clinical development.
Abstract
Optimizing Clinically Actionable Biomarker Detection in Advanced Cancers by Next Generation Sequencing (NGS) Panel and Specimen Type
This abstract evaluates matched cancer tissue and circulating tumor DNA (ctDNA) specimens from patients with advanced solid tumors to compare biomarker detection across different next-generation sequencing (NGS) strategies. The findings demonstrate how tissue and ctDNA provide complementary genomic insights that can support more informed precision oncology decision-making.
Webinar
Next-Generation Sequencing Applications for Antiviral Drug Development
As antiviral therapies continue to evolve, accurately detecting low-frequency viral variants is essential for evaluating therapeutic efficacy, monitoring resistance, and supporting regulatory submissions. This webinar highlights how next-generation sequencing (NGS) is being applied to identify minority variants with greater sensitivity than traditional sequencing methods.
Advance your genomics program
